Abstract
Personalized medicine offers a custom-made treatment for each patient directed by information of individuals genetic variation. Despite plenty of information about human single nucleotide polymorphisms (SNPs) and gene expression profile, predicting functions of genetic variations in humans is still a difficult task. Genetic analysis using experimental animals is possible to provide information about the functions of genetic polymorphisms over experimental invention in humans. In particular, inbred strains established from wild mice are valuable resources for analyzing functions of genetic polymorphisms. In this article, first I describe history of inbred strains derived from Japanese wild mice, Mus musuclus molossinus. Next, I discuss a mouse model for hyperlipidemia, which was isolated from a colony of Japanese wild mice. Interestingly, the hyperlipimic phenotypes are varied in congenic strains on other genetic backgrounds, reflecting phenotype variation of hyperlipidemia in human populations. Thus, further genetic analysis of Japanese wild mice can contribute to functional analysis of human genetic variation leading to personalized medicine.
Keywords: Polymorphisms, Wild Mice, nucleotide, Mus musuclus molossinus, genetic variation
Current Pharmaceutical Biotechnology
Title: The New Disease Models from Genetic Polymorphisms of Japanese Wild Mice
Volume: 10 Issue: 2
Author(s): Yoshibumi Matsushima
Affiliation:
Keywords: Polymorphisms, Wild Mice, nucleotide, Mus musuclus molossinus, genetic variation
Abstract: Personalized medicine offers a custom-made treatment for each patient directed by information of individuals genetic variation. Despite plenty of information about human single nucleotide polymorphisms (SNPs) and gene expression profile, predicting functions of genetic variations in humans is still a difficult task. Genetic analysis using experimental animals is possible to provide information about the functions of genetic polymorphisms over experimental invention in humans. In particular, inbred strains established from wild mice are valuable resources for analyzing functions of genetic polymorphisms. In this article, first I describe history of inbred strains derived from Japanese wild mice, Mus musuclus molossinus. Next, I discuss a mouse model for hyperlipidemia, which was isolated from a colony of Japanese wild mice. Interestingly, the hyperlipimic phenotypes are varied in congenic strains on other genetic backgrounds, reflecting phenotype variation of hyperlipidemia in human populations. Thus, further genetic analysis of Japanese wild mice can contribute to functional analysis of human genetic variation leading to personalized medicine.
Export Options
About this article
Cite this article as:
Matsushima Yoshibumi, The New Disease Models from Genetic Polymorphisms of Japanese Wild Mice, Current Pharmaceutical Biotechnology 2009; 10 (2) . https://dx.doi.org/10.2174/138920109787315097
DOI https://dx.doi.org/10.2174/138920109787315097 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Brachial-Ankle Pulse Wave Velocity in the Measurement of Arterial Stiffness: Recent Evidence and Clinical Applications
Current Hypertension Reviews Vascular Abnormalities in Essential Hypertension
Current Pharmaceutical Design Hybrid PET Imaging in Neurologic Disease: PET/MRI Rather than PET/CT
Current Medical Imaging 3D CT Angiography of Infrarenal Abdominal Aortic Aneurysm with Associated Ectopic Pelvic Kidney: A Case Report of Rare Concomitance
Current Medical Imaging Cardioprotective Effects of Natural Products <i>via</i> the Nrf2 Signaling Pathway
Current Vascular Pharmacology Molecular Targeted Agents Combined with Chemo-Radiation in the Treatment of Locally Advanced Cervix Cancer
Reviews on Recent Clinical Trials Targeting RANK/RANKL in the Treatment of Solid Tumours and Myeloma
Current Pharmaceutical Design Cyclophilins in Atherosclerosis: A New Therapeutic Target?
Current Pharmaceutical Design Beta-Blockers use for Hypertension in the Elderly
Cardiovascular & Hematological Agents in Medicinal Chemistry Mesenchymal Stem Cells: A Good Candidate for Restenosis Therapy?
Current Vascular Pharmacology Emerging Therapeutic Agents for Cervical Cancer
Recent Patents on Anti-Cancer Drug Discovery Serum Vitamin E (α-Tocopherol) Estimation: A Potential Biomarker of Antioxidant Status Evaluation on Heavy Metal Toxicities
Recent Patents on Biomarkers Fractal Analysis of the Bone Marrow in Myelodysplastic Syndromes
Current Bioinformatics Infectious Burden: A New Risk Factor and Treatment Target for Atherosclerosis
Infectious Disorders - Drug Targets The Coronary Circulation in Arterial Hypertension
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Microbial Agents, Immune Function and Atheromatosis: The Chlamydophila pneumoniae Role
Current Immunology Reviews (Discontinued) Significance of Inorganic Nitrate Supplement in Cardiovascular Health
Cardiovascular & Hematological Agents in Medicinal Chemistry Antioxidant Response of Osteoblasts to Doxycycline in an Inflammatory Model Induced by C-reactive Protein and Interleukin-6
Infectious Disorders - Drug Targets Lifestyle Choices and Endothelial Function: Risk and Relevance
Current Vascular Pharmacology Relationship between Augmentation Index and Wall Thickening Fraction during Hypotension in an Animal Model of Myocardial Ischemia-Reperfusion and Heart Failure
Current Hypertension Reviews